Vir Biotechnology, Inc. (VIR)
10.74
+0.53
(+5.19%)
USD |
NASDAQ |
Oct 20, 16:00
10.75
+0.01
(+0.09%)
After-Hours: 07:27
Vir Biotechnology Gross Profit (TTM) : 291.70M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 291.70M |
| March 31, 2026 | 53.84M |
| December 31, 2025 | 56.85M |
| September 30, 2025 | 4.508M |
| June 30, 2025 | 6.689M |
| March 31, 2025 | 7.166M |
| December 31, 2024 | 58.80M |
| September 30, 2024 | 61.51M |
| June 30, 2024 | 58.27M |
| March 31, 2024 | 56.31M |
| December 31, 2023 | 57.75M |
| September 30, 2023 | 87.70M |
| June 30, 2023 | 442.12M |
| March 31, 2023 | 375.18M |
| December 31, 2022 | 1.461B |
| September 30, 2022 | 2.173B |
| Date | Value |
|---|---|
| June 30, 2022 | 1.916B |
| March 31, 2022 | 2.159B |
| December 31, 2021 | 1.020B |
| September 30, 2021 | 265.80M |
| June 30, 2021 | 173.00M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Moderna, Inc. | 280.00M |
| Vaxcyte, Inc. | -26.78M |
| Caribou Biosciences, Inc. | 7.448M |
| Arrowhead Pharmaceuticals, Inc. | 643.69M |
| Oncolytics Biotech, Inc. | -0.11M |